#USA #Washington D.C. #Solis Mammography #Breast Health

Solis Mammography Expands into Washington D.C.

Solis Mammography, recognized as the leading independent provider of specialized breast health services in the United States, has officially launched a new screening mammography center in Washington D.C. This location represents the company's first service point in the DMV (D.C., Maryland, Virginia) market, aiming to enhance breast health accessibility for women in the region.

With a legacy of nearly 40 years dedicated to the early detection of breast cancer, Solis Mammography has cultivated a substantial presence in over 150 communities across the nation. The new center is a reflection of the company’s commitment to extending its innovative approach to breast health to the D.C. area, which is particularly vital in a city that necessitates advanced medical services to its diverse population.

State-of-the-Art Services

The Washington D.C. center is outfitted with cutting-edge technology designed to elevate the mammogram experience. Among its features, it integrates artificial intelligence (AI) software with 3D mammography, a significant advancement that bolsters diagnostic accuracy and facilitates the early detection of cancer at more manageable stages. Moreover, the facility incorporates SmartCurve technology—a revolutionary breast compression system shaped to fit the anatomical contours of a woman’s breast, thereby increasing comfort during the mammogram process.

An additional innovative service, Mammo+Heart, offers patients heart health insights simultaneous with their mammography. This option detects breast arterial calcification, a marker that has been associated with an elevated risk for cardiovascular diseases in women. This holistic approach to health screening showcases Solis Mammography’s dedication to not just breast health, but overall wellness.

Patient-Centric Environment

Designed with patient comfort in mind, the new center provides an inviting space where comfort and care converge. The convenient downtown location ensures accessibility, with options for walk-ins and ample on-site parking, as well as easy access to public transportation. Furthermore, a team of specialized technologists and physicians proficient in breast health is on hand to guide patients through their experiences, ensuring each individual receives exceptional care tailored to their needs.

CEO Remarks

Grant Davies, CEO of Solis Mammography, articulated the significance of this expansion by stating, “Our move into the D.C. market not only illustrates our rapidly growing footprint but reinforces our commitment to facilitating greater access to sophisticated mammography services nationwide. The specialized clinical expertise we bring, coupled with our focus on innovation and prioritizing patient experience, is transforming how mammography is experienced by our patients. We are excited to be catering to women in the metropolitan D.C. area.”

Location and Future Prospects

The new Solis Mammography center is located at 1145 19th Street NW, Suite 101, Washington, DC, and is now welcoming new patients. This opening marks a significant step in Solis Mammography’s goal to provide premier access to breast health services. To learn more about the offerings at Solis Mammography’s 19th Street center, visit their website at SolisMammo.com.

About Solis Mammography

For four decades, Solis Mammography has dedicated itself to improving mammography services and enhancing breast health management for women. Headquartered in Addison, Texas, the organization operates over 150 centers across 22 major markets, including major cities like Dallas-Fort Worth, Houston, and now Washington D.C. Solis Mammography is redefining the patient experience in healthcare by creating high-quality, boutique-style mammography centers that prioritize service and care.

This latest expansion is merely a chapter in Solis Mammography's ongoing expansion into new territories, ensuring that more women have access to the vital services that can make a significant impact on their health outcomes.